National Cancer Center Korea
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ncc.re.kr
Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
- Conditions
- Pancreas Cancer
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 120
- Registration Number
- NCT04466189
- Locations
- 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of
Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients
Not Applicable
Completed
- Conditions
- Stage I Gastric Cancer
- Interventions
- Behavioral: smart phone app based human coaching program
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 180
- Registration Number
- NCT04394585
- Locations
- 🇰🇷
Bang Wool Eom, Goyang, Gyeonggi-do, Korea, Republic of
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural
Phase 2
- Conditions
- Pancreatic CancerBiliary Tract Neoplasms
- Interventions
- Procedure: Patient-controlled analgesia
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 110
- Registration Number
- NCT04352023
- Locations
- 🇰🇷
National Cancer Center, Goyang, Gyeonggi, Korea, Republic of
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
Recruiting
- Conditions
- Rectal Cancer
- First Posted Date
- 2020-02-27
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 210
- Registration Number
- NCT04287400
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
Completed
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 238
- Registration Number
- NCT04281511
- Locations
- 🇰🇷
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si, Gyeonggi-do, Korea, Republic of
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
Active, not recruiting
- Conditions
- Pancreas Adenocarcinoma
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 420
- Registration Number
- NCT04241367
- Locations
- 🇰🇷
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si, Gyeonggi-do, Korea, Republic of
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Phase 3
Recruiting
- Conditions
- Gastric CancerAspirin
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 1700
- Registration Number
- NCT04214990
- Locations
- 🇰🇷
Pusan National University Hospital, Busan, Korea, Republic of
🇰🇷Kosin University Gospel Hospital, Busan, Korea, Republic of
🇰🇷Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea, Republic of
Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy
- Conditions
- Breast Cancer
- First Posted Date
- 2019-12-18
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 5000
- Registration Number
- NCT04203849
- Locations
- 🇰🇷
National Cancer Center Korea, Goyang, Gyeonggi, Korea, Republic of
Comparison of Diagnostic Performance of Medical Monitor and Medical Augmented Reality Glasses in Endoscopy: Observation Study
- Conditions
- Early Gastric Cancer
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 25
- Registration Number
- NCT04083573
EGFR-targeted Therapy for Gastric Cancer
Phase 2
Recruiting
- Conditions
- Adenocarcinoma of the Stomach
- Interventions
- Drug: Anti-EGFR antibody in combination with weekly paclitaxel
- First Posted Date
- 2019-09-04
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 19
- Registration Number
- NCT04077255
- Locations
- 🇰🇷
National Cancer Center, Goyang, Gyeonggi, Korea, Republic of